Jane Street
MRNS

Jane Street’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Jane Street’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,700
Closed -$467K – 10451
2024
Q1 		$467K Buy
+51,700
New +$503K ﹤0.01% 6798
2023
Q3 		– Sell
-15,700
Closed -$171K – 9594
2023
Q2 		$171K Buy
+15,700
New +$134K ﹤0.01% 7744
2021
Q3 		– Sell
-23,800
Closed -$427K – 10955
2021
Q2 		$427K Sell
23,800
-17,100
-42% -$275K ﹤0.01% 7531
2021
Q1 		$633K Buy
+40,900
New +$592K ﹤0.01% 6368
2020
Q4 		– Sell
-20,325
Closed -$261K – 8274
2020
Q3 		$261K Buy
+20,325
New +$175K ﹤0.01% 6083

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's MRNS Position: Q4 2024 in Review

Jane Street sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 45,549 shares — an estimated $80.2K sold.

Jane Street first reported a position in MRNS in Q3 2018 and held it in 20 quarters. The position peaked at $2.1M in Q1 2023. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Jane Street reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Jane Street sold 45,549 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $80.2K.
  • Jane Street first reported a position in Marinus Pharmaceuticals, Inc in Q3 2018 and held it in 20 quarters.
  • Jane Street's Marinus Pharmaceuticals, Inc position peaked at $2.1M in Q1 2023.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.